financetom
Business
financetom
/
Business
/
Great-West Lifeco Reports Record Third-Quarter Base Earnings
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Great-West Lifeco Reports Record Third-Quarter Base Earnings
Nov 9, 2024 11:45 AM

05:37 PM EST, 11/06/2024 (MT Newswires) -- Great-West Lifeco ( GWLIF ) on Wednesday reported higher third-quarter base earnings.

Base earnings of $1.06 billion or $1.14 per share, was a record and a 12% increase from $950 million or $1.02, last year. The increase reflects pre-tax growth and higher earnings from all segments, partially offset by the Global Minimum Tax (GMT) in the Capital and Risk Solutions and Europe segments.

Net earnings from continuing operations fell 9% to $859 million or $0.92 per share, reflecting less favorable impacts of relative interest rate movements. Last year's result included reductions in commercial property values in the Europe segment, the company said.

Base ROE of 17.3%, compares with last year's 16.4%.

Great-West will pay a quarterly dividend of $0.555 per share, on December 3.

"We continue to execute on our focused strategies to deliver sustainable and profitable growth for our shareholders. In our fifth consecutive quarter of record base earnings, we're delivering at the top end of our medium-term financial objectives," said Paul Mahon, President and CEO, Great-West Lifeco ( GWLIF ). "We have strong underlying momentum across all of our segments, and we have delivered on key actions to support and accelerate our growth strategies in both the U.S. and Canada."

Great-West closed $0.35 higher, to $47.55, on the Toronto Stock Exchange.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sunho Biologics Gets Green Light For Downsized IPO
Sunho Biologics Gets Green Light For Downsized IPO
Apr 26, 2024
The market conditions may be dire, but Chinese drug developer Sunho Biologics Inc. needs the cash. The loss-making biotech has secured the green light for an IPO, but the Hong Kong market is in a prolonged slump and has hardly been fertile ground for new listings. In the first quarter of the year, only 12 companies managed to debut in Hong Kong,...
IBM Delivers on Two Key Metrics in 'Solid' Q1 Despite Revenue Miss, RBC Says
IBM Delivers on Two Key Metrics in 'Solid' Q1 Despite Revenue Miss, RBC Says
Apr 26, 2024
12:13 PM EDT, 04/26/2024 (MT Newswires) -- International Business Machines ( IBM ) delivered on free cash flow and Red Hat sales in Q1 for a solid start to the year despite trailing estimates on total revenue, RBC Capital Markets said Thursday in a report. The highlight from our perspective was the performance of our two focal metrics with free...
Vertex Pharmaceuticals Gets European Commission Approval for Cystic Fibrosis Treatment for Infants
Vertex Pharmaceuticals Gets European Commission Approval for Cystic Fibrosis Treatment for Infants
Apr 26, 2024
12:11 PM EDT, 04/26/2024 (MT Newswires) -- Vertex Pharmaceuticals ( VRTX ) said Friday it received the European Commission's approval for Kalydeco, or ivacaftor, to treat infants with cystic fibrosis aged one month and older. Cystic fibrosis is a rare, life-shortening multi-organ genetic disease. The company said eligible patients will have access to the expanded indication of Kalydeco shortly following...
Northrop Grumman's Q1 Results Highlight Favorable Margins, International Growth Prospects, RBC Says
Northrop Grumman's Q1 Results Highlight Favorable Margins, International Growth Prospects, RBC Says
Apr 26, 2024
12:07 PM EDT, 04/26/2024 (MT Newswires) -- Northrop Grumman's ( NOC ) strong Q1 results were driven by sales growth in aeronautics and space segments as well as better-than-expected operating margins, RBC said in a note emailed Friday. The company's favorable margin outlook has garnered positive investor sentiment, with anticipated improvements due to potential upside in 2024 and 2025, and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved